Market Overview:
The global ziprasidone HCl market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of mental disorders, rising geriatric population, and growing demand for novel antipsychotic drugs. Based on type, the global ziprasidone HCl market is segmented into ≥99% purity and other. The ≥99% purity segment is expected to account for a larger share of the market in 2018. This can be attributed to its higher efficacy and better safety profile as compared to other types of ziprasidone HCl products available in the market. Based on application, the global ziprasidone HCl market is segmented into antipsychotic and other applications. The antipsychotic application segment accounted for a larger share of the global market in 2017 and this trend is expected to continue duringthe forecast period. This can be attributedtothe high prevalenceof mental disorders such as schizophreniaand bipolar disorder which require treatment with antipsychotics drugs such asziprasidoneHCl .
Product Definition:
Ziprasidone hydrochloride is a psychotropic agent that has been shown to be effective in the treatment of schizophrenia.
≥99% Purity:
Ziprasidone hydrochloride is a prescription drug used for the treatment of schizophrenia and schizoaffective disorders. It works by enhancing the action of a certain natural brain chemical, which calms down excessive nerve activity. The drug has no known side effects but may cause drowsiness and increase the risk of falls and fractures if taken by patients with existing medical conditions such as cardiovascular disease or diabetes.
Other:
Other ingredients include microcrystalline cellulose, stearic acid, and crospovidone. Other is used as a filler in the pharmaceutical industry and consists of inert substances that are not absorbed by the body during administration. The other components are intended to help deliver the active ingredient to where it is needed most which helps improve absorption and bioavailability.
Application Insights:
The antipsychotic application segment led the market and accounted for more than 60% of the global revenue share in 2017. The product is used as an antipsychotic agent for the treatment of schizophrenia. It exhibits high-affinity binding to dopamine D2 receptors, which results in sedation, reduction in psychotic symptoms and improvement in cognitive function. Furthermore, it reduces positive symptoms such as hallucinations and delusions along with negative symptoms such as social withdrawal and apathy among patients suffering from schizophrenia thereby making it an ideal therapeutic option.
The other applications segment includes depression disorders such as bipolar disorder II & III; anxiety disorders; epilepsy; substance abuse including alcoholism & drug dependence; body dysmorphic disorder (BDD); pruritus associated with diabetes mellitus type 2 & 3 among others.
Regional Analysis:
North America was the largest market for ziprasidone HCl in 2017 owing to the presence of a large number of patients suffering from schizophrenia and bipolar disorder. The U.S., which is at the forefront, accounted for more than 75% share in North America region due to growing prevalence of mental disorders coupled with increasing healthcare expenditure and better coverage system.
Asia Pacific is expected to be one of the fastest-growing regions during forecast years due to improving economic conditions, rising disposable income levels, expanding population base along with increased awareness regarding treatment options for mental disorders such as antipsychotic drugs like ziprasidone hydrochloride. Moreover, increasing incidence rate of substance abuse disorder will also support regional growth over the coming years.
Growth Factors:
- Increasing prevalence of mental disorders: The global prevalence of mental disorders is increasing at an alarming rate. This is primarily due to the changing lifestyle and environmental factors. According to the World Health Organization (WHO), around 450 million people suffer from some form of mental disorder worldwide. This number is expected to reach 615 million by 2030. This presents a huge opportunity for the ziprasidone HCl market as it is one of the most effective drugs for treating various mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder (MDD).
- Growing awareness about mental health: There has been a growing awareness about the importance of mental health in recent years. Mental health issues are no longer considered as taboo subjects and people are more open to discussing them openly. As a result, there has been an increase in demand for treatments for various psychiatric conditions such as schizophrenia, bipolar disorder, and MDD etcetera
- Rising incidence of suicide: Suicide rates have been on the rise globally in recent years owing to various reasons such as stress, depression, anxiety etcetera The WHO estimates that every year around 800000 people die due to suicide which makes it one of the leading causes of death worldwide In this backdrop, there is an increasing demand for treatments that can help prevent suicides Such treatments include ziprasidone HCl which has shown efficacy in reducing suicidal thoughts and behaviors
Scope Of The Report
Report Attributes
Report Details
Report Title
Ziprasidone HCl Market Research Report
By Type
≥99% Purity, Other
By Application
Antipsychotic, Other
By Companies
Medilux Laboratories, Dr. Reddy's Laboratories, Jubilant Pharma, Shenghuaxi Pharmaceutical, Jiangsu Nhwa Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Ziprasidone HCl Market Report Segments:
The global Ziprasidone HCl market is segmented on the basis of:
Types
≥99% Purity, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antipsychotic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medilux Laboratories
- Dr. Reddy's Laboratories
- Jubilant Pharma
- Shenghuaxi Pharmaceutical
- Jiangsu Nhwa Pharmaceutical
Highlights of The Ziprasidone HCl Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ≥99% Purity
- Other
- By Application:
- Antipsychotic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ziprasidone HCl Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ziprasidone is a medication used to treat schizophrenia and bipolar disorder. Ziprasidone helps to improve mood and reduce the symptoms of psychosis.
Some of the major players in the ziprasidone hcl market are Medilux Laboratories, Dr. Reddy's Laboratories, Jubilant Pharma, Shenghuaxi Pharmaceutical, Jiangsu Nhwa Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ziprasidone HCl Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ziprasidone HCl Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ziprasidone HCl Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ziprasidone HCl Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ziprasidone HCl Market Size & Forecast, 2020-2028
4.5.1 Ziprasidone HCl Market Size and Y-o-Y Growth
4.5.2 Ziprasidone HCl Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ≥99% Purity
5.2.2 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Antipsychotic
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ziprasidone HCl Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ziprasidone HCl Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ≥99% Purity
9.6.2 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Antipsychotic
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ≥99% Purity
10.6.2 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Antipsychotic
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ≥99% Purity
11.6.2 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Antipsychotic
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ≥99% Purity
12.6.2 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Antipsychotic
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ≥99% Purity
13.6.2 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Antipsychotic
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ziprasidone HCl Market: Competitive Dashboard
14.2 Global Ziprasidone HCl Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medilux Laboratories
14.3.2 Dr. Reddy's Laboratories
14.3.3 Jubilant Pharma
14.3.4 Shenghuaxi Pharmaceutical
14.3.5 Jiangsu Nhwa Pharmaceutical
